Literature DB >> 10454544

Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

L Pan1, S Sato, J P Frederick, X H Sun, Y Zhuang.   

Abstract

B-lymphocyte activation and proliferation induced by the B-cell receptor (BCR) signals are important steps in the initiation of humoral immune responses. How the BCR signals are translated by nuclear transcription factors into cell cycle progression is poorly understood. Id3 is an immediate-early gene responding to growth and mitogenic signals in many cell types including B cells. The primary function of the Id3 protein has been defined as that of inhibitor of basic-helix-loop-helix (bHLH) transcription factors. The interaction between Id3 and bHLH proteins, many of which are essential for cellular differentiation, has been proposed as a key regulatory event leading to cellular proliferation instead of differentiation. To further investigate the role of Id3 in tissue and embryo development and the mechanism of Id3-mediated growth regulation, we generated and analyzed Id3-deficient mice. While these mice display no overt abnormality in tissue and embryo development, their humoral immunity is compromised. The amounts of immunoglobulins produced in Id3-deficient mice immunized with a T-cell-dependent antigen and a type 2 T-cell-independent antigen are attenuated and severely impaired, respectively. Further analysis of lymphocytes isolated from Id3-deficient mice reveals a B-cell defect in their proliferation response to BCR cross-linking but not to lipopolysaccharide or a combination of BCR cross-linking and interleukin-4. Analyses of cultured lymphocytes also suggest involvement of Id3 in cytokine production in T cells and isotype switching in B cells. Finally, the proliferation defect in Id3-deficient B cells can be rescued by ectopic expression of Id1, a homologue of Id3. Taken together, these results define a necessary and specific role for Id3 in mediating signals from BCR to cell cycle progression during humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454544      PMCID: PMC84466          DOI: 10.1128/MCB.19.9.5969

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.

Authors:  S Sato; N Ono; D A Steeber; D S Pisetsky; T F Tedder
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

2.  Functional replacement of the mouse E2A gene with a human HEB cDNA.

Authors:  Y Zhuang; R J Barndt; L Pan; R Kelley; M Dai
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.

Authors:  M E Massari; R R Rivera; J R Voland; M W Quong; T M Breit; J J van Dongen; O de Smit; C Murre
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.

Authors:  W Yan; A Z Young; V C Soares; R Kelley; R Benezra; Y Zhuang
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.

Authors:  R W Deed; E Hara; G T Atherton; G Peters; J D Norton
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching.

Authors:  A N Goldfarb; J P Flores; K Lewandowska
Journal:  Mol Immunol       Date:  1996-08       Impact factor: 4.407

7.  E47 activates the Ig-heavy chain and TdT loci in non-B cells.

Authors:  J K Choi; C P Shen; H S Radomska; L A Eckhardt; T Kadesch
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

8.  Repression of the immunoglobulin heavy chain 3' enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental control of enhancer function.

Authors:  K B Meyer; M Skogberg; C Margenfeld; J Ireland; S Pettersson
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

9.  Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1.

Authors:  P Y Desprez; E Hara; M J Bissell; J Campisi
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction.

Authors:  M B Datto; J P Frederick; L Pan; A J Borton; Y Zhuang; X F Wang
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

View more
  66 in total

1.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  Genome-scale study of transcription factor expression in the branching mouse lung.

Authors:  John C Herriges; Lan Yi; Elizabeth A Hines; Julie F Harvey; Guoliang Xu; Paul A Gray; Qiufu Ma; Xin Sun
Journal:  Dev Dyn       Date:  2012-07-20       Impact factor: 3.780

5.  Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Authors:  Daniel B Harmon; Prasad Srikakulapu; Jennifer L Kaplan; Stephanie N Oldham; Chantel McSkimming; James C Garmey; Heather M Perry; Jennifer L Kirby; Thomas A Prohaska; Ayelet Gonen; Peter Hallowell; Bruce Schirmer; Sotirios Tsimikas; Angela M Taylor; Joseph L Witztum; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-11       Impact factor: 8.311

6.  Id3 is a direct transcriptional target of Pax7 in quiescent satellite cells.

Authors:  Deepak Kumar; Jennifer L Shadrach; Amy J Wagers; Andrew B Lassar
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

7.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

8.  B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.

Authors:  Ikuko Hayakawa; Thomas F Tedder; Yuan Zhuang
Journal:  Immunology       Date:  2007-04-30       Impact factor: 7.397

9.  Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.

Authors:  Yumi Yashiro-Ohtani; Yiping He; Takuya Ohtani; Mary E Jones; Olga Shestova; Lanwei Xu; Terry C Fang; Mark Y Chiang; Andrew M Intlekofer; Stephen C Blacklow; Yuan Zhuang; Warren S Pear
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

10.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.